Related references
Note: Only part of the references are listed.Differences in clinicopatholgic characteristics and risk of mortality between the triple positive and ER+/PR+/HER2-breast cancer subtypes
Carol A. Parise et al.
CANCER CAUSES & CONTROL (2019)
Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups
Oscar M. Rueda et al.
NATURE (2019)
Using clinical cancer registry data for estimation of quality indicators: Results from the Norwegian breast cancer registry
Olaf Johan Hartmann-Johnsena et al.
INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS (2019)
Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline
N. Lynn Henry et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort
Anna L. V. Johansson et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Stage-specific incidence and survival of breast cancer in Norway: The implications of changes in coding and classification practice
Inger Kristin Larsen et al.
BREAST (2018)
Differences in Breast Cancer Survival by Molecular Subtypes in the United States
Nadia Howlader et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2018)
PAM50 Risk of Recurrence Score Predicts 10-Year Distant Recurrence in a Comprehensive Danish Cohort of Postmenopausal Women Allocated to 5 Years of Endocrine Therapy for Hormone Receptor-Positive Early Breast Cancer
Anne-Vibeke Laenkholm et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
J. A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Impact of subtypes and comorbidities on breast cancer relapse and survival in population-based studies
Silvia M. Ess et al.
BREAST (2018)
Breast cancer in young women and prognosis: How important are proliferation markers?
Hanna Fredholm et al.
EUROPEAN JOURNAL OF CANCER (2017)
Breast Cancer Molecular Stratification From Intrinsic Subtypes to Integrative Clusters
Hege G. Russnes et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
G. Curigliano et al.
ANNALS OF ONCOLOGY (2017)
St Gallen 2015 subtyping of luminal breast cancers: impact of different Ki67-based proliferation assessment methods
Cornelia M. Focke et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
F. Cardoso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
A. S. Coates et al.
ANNALS OF ONCOLOGY (2015)
Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study
Li Tao et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173 797 patients
Sepideh Saadatmand et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173 797 patients
Sepideh Saadatmand et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes
Patrick Maisonneuve et al.
BREAST CANCER RESEARCH (2014)
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2013)
Breast cancer survival in the US and Europe: a CONCORD high-resolution study
Claudia Allemani et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer
Katrina Bauer et al.
BMC CANCER (2010)
Intrinsic Breast Tumor Subtypes, Race, and Long-Term Survival in the Carolina Breast Cancer Study
Katie M. O'Brien et al.
CLINICAL CANCER RESEARCH (2010)
Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness
Inger Kristin Larsen et al.
EUROPEAN JOURNAL OF CANCER (2009)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Further development of flexible parametric models for survival analysis
Paul C. Lambert et al.
STATA JOURNAL (2009)
Understanding the molecular basis of histologic grade
M. Ignatiadis et al.
PATHOBIOLOGY (2008)
Descriptive analysis of estrogen receptor (ER)negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype - A population-based study from the California Cancer Registry
Katrina R. Bauer et al.
CANCER (2007)
Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade
Sherene Loi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer
Anna V. Ivshina et al.
CANCER RESEARCH (2006)
Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis
C Sotiriou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe
M Sant et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects
P Royston et al.
STATISTICS IN MEDICINE (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
